Table 2.
Newly diagnosed cases |
Tumor response evaluation1 |
Follow-up period (mo) | Survival2 | |
Target lesion 2 mo post-TEA | Time to progress (mo) | |||
1 | CR | 9.9 | 16.8 | Yes |
2 | CR | 6.1 | 14.1 | Yes |
3 | PR | 6.3 | 9.5 | Yes |
4 | PR | 5.1 | 7.5 | Yes |
5 | PR | 0 | 6.3 | Yes |
RECIST version 1.1;
Survival (yes), death (no). TEA: Transarterial embolization ablation; CR: Complete response; PR: Partial response.